ARYX (ARYx Therapeutics) Beginning Cash Position: $1.40 Mil (As of Sep. 2010)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is ARYx Therapeutics Beginning Cash Position?

ARYx Therapeutics ARYX -99.80% Beginning Cash Position is $1.40 Mil as of Sep. 2010.

ARYx Therapeutics's Beginning Cash Position for the quarter that ended in Sep. 2010 was $1.40 Mil.

ARYx Therapeutics's quarterly Beginning Cash Position declined from Mar. 2010 ($7.41 Mil) to Jun. 2010 ($6.30 Mil) and declined from Jun. 2010 ($6.30 Mil) to Sep. 2010 ($1.40 Mil).

ARYx Therapeutics's annual Beginning Cash Position increased from Dec. 2007 ($18.66 Mil) to Dec. 2008 ($55.48 Mil) but then declined from Dec. 2008 ($55.48 Mil) to Dec. 2009 ($36.00 Mil).

ARYx Therapeutics Beginning Cash Position Related Terms

ARYx Therapeutics Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for ARYx Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ARYx Therapeutics Beginning Cash Position Chart

ARYx Therapeutics Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09
Beginning Cash Position
Get a 7-Day Free Trial 14.18 12.46 18.66 55.48 36.00

ARYx Therapeutics Quarterly Data
Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.93 6.85 7.41 6.30 1.40

ARYx Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $1.40 Mil mean?
ARYx Therapeutics (ARYX) has a Beginning Cash Position of $1.40 Mil as of Sep. 2010. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on ARYx Therapeutics and its competitors.
Is ARYx Therapeutics' Beginning Cash Position too high?
ARYx Therapeutics' current Beginning Cash Position is $1.40 Mil.
How does ARYx Therapeutics' Beginning Cash Position compare to YBAO and HPMM?
ARYx Therapeutics' Beginning Cash Position of $1.40 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on ARYx Therapeutics and its competitors. ARYx Therapeutics's current Beginning Cash Position is $1.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ARYx Therapeutics stock overvalued right now?
ARYx Therapeutics (ARYX) has a current Beginning Cash Position of $1.40 Mil. The current Beginning Cash Position is $1.40 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For ARYx Therapeutics (ARYX), the current Beginning Cash Position is $1.40 Mil as of Sep. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ARYx Therapeutics Business Description

Address 6300 Dumbarton Circle, Fremont, CA, USA, 94555
ARYx Therapeutics Inc is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs.